PUT - SPRINTER OPEN END - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 11:13:13 15/05/2024 pm IST | ||
| 3.87 EUR | -0.77% |
|
| Current month | -2.03% | ||
| 1 month | +8.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 15/24/15 | 3.87 | -0.77% |
| 14/24/14 | 3.9 | +1.04% |
| 13/24/13 | 3.86 | -1.03% |
| 10/24/10 | 3.9 | -1.27% |
| 09/24/09 | 3.95 | -1.50% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 11:13 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VX9YGF |
| ISIN | DE000VX9YGF2 |
| Date issued | 08/04/2022 |
| Strike | 86.76 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.02 € |
|---|---|
| Lowest since issue | 0.7 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
44.71
USD
Average target price
53.19
USD
Spread / Average Target
+18.98%
- Stock Market
- Certificates
- Certificat
